September 26, 2016 4:33 PM ET

Biotechnology

Company Overview of Innovir Laboratories Inc.

Company Overview

As per the transaction announced in August 1999, Innovir Laboratories, Inc. was acquired by Sirna Therapeutics Inc. Innovir Laboratories, Inc. develops technology to be used as a research tool to facilitate determination of gene function, and to validate drug targets. The company continues to seek partners, investors or purchasers for its core oligozyme technology including the lead EGS, the FRS/GSFRS, the RILON technology and related research technologies. Innovir has no commercially viable therapeutic products, and does not anticipate having any for several years. Since its inception, substantially all of its resources have been applied to research and development, patents and licensing, a...

510 E 73rd St

New York, NY 10021

United States

44 Employees

Phone:

212-249-4703

Key Executives for Innovir Laboratories Inc.

Innovir Laboratories Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Innovir Laboratories Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.